What monitoring is recommended for routine patient management with bimekizumab to assess liver enzyme levels?

Featuring April Armstrong, MD, MPH | Co-Director | Professor and Chief, Division of Dermatology, University of California Los Angeles (UCLA), Los Angeles, CA, USA | Published January 01, 2024